Latest news with #CellivateTechnologies
&w=3840&q=100)
Business Standard
31-07-2025
- Business
- Business Standard
IPV launches $110 mn angel fund in GIFT City to tap global startup capital
Angel investment platform Inflection Point Ventures (IPV) on Thursday announced the launch of a $110 million Category I Angel Fund—IPV International—under the International Financial Services Centres Authority (IFSCA) framework at GIFT City. The fund will lead or participate in early-stage to pre-Series A funding rounds, with investment ticket sizes ranging from $100,000 to $1 million. The fund recorded its first close in April. First investment in Singapore's Cellivate Technologies IPV International has already made its maiden investment in Singapore-based deeptech startup Cellivate Technologies. The company is developing an ethical and scalable alternative to fetal bovine serum using magnetic stimulation, targeting applications across biotech, pharma, and adjacent sectors. 'A presence in GIFT City enables us to scale beyond national borders, engage with global startup ecosystems, and remain aligned with the rapidly shifting dynamics of the venture capital and private equity markets,' said Vinay Bansal, Founder and CEO of IPV. Bansal added that the fund has attracted significant interest not just from Indians and NRIs but also from non-Indian investors looking to enter India's booming startup ecosystem, with the GIFT City framework providing a favourable gateway. Backed by 50 successful exits, IPV aims to scale globally 'With a proven track record including 50 successful exits from a portfolio of over 220 startups, IPV is now set to leverage this experience and scale its platform to reach both national and international investors through IPV International,' said Mitesh Shah, Co-founder of IPV. In addition to IPV International, the firm has launched a $50 million Category II venture capital fund—Physis Capital—to back Pre-Series A to Series B growth-stage startups. The fund has so far invested in six startups, with several other deals in advanced stages. 'By leveraging the global access provided by the GIFT City platform, we're now well-positioned to invest in innovative ventures across international markets, enhancing both portfolio diversification and investor value,' said Ankur Mittal, Co-founder of IPV.
Time of India
31-07-2025
- Business
- Time of India
Early-stage angel investing platform IPV launches $110 million international fund from GIFT City
Synopsis IPV International will invest between $100,000 and $1 million per startup. The fund said on Thursday that it has already made its first investment, in Cellivate Technologies, a Singapore-based deeptech startup.
Entrepreneur
31-07-2025
- Business
- Entrepreneur
Inflection Point Ventures Launches USD 110 Million Angel Fund 'IPV International' via GIFT City
While the fund is sector-agnostic, it will maintain a focus on select high-growth areas You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Inflection Point Ventures (IPV), an Indian angel investment platform, has launched a new international fund, IPV International, with a total corpus of USD 110 million. The fund, registered as a Category I Angel Fund under GIFT City's International Financial Services Centres Authority (IFSCA), is now operational and marks a step toward broadening cross-border investment access for both domestic and international investors. The first close of the fund took place in April 2025. IPV International has already made its first investment in Singapore-based Cellivate Technologies, a deeptech startup developing a scalable, ethical alternative to fetal bovine serum for use in biotech and pharmaceutical research. While the fund is sector-agnostic, it will maintain a focus on select high-growth areas. Ticket sizes for investments range from USD 100,000 to USD1 million, targeting early to pre-Series A-stage startups. The fund has secured the necessary registration and fund management licenses from IFSCA, enabling full operation within GIFT City's regulatory framework. One key feature of IPV International is its structure, which enables participation from non-resident Indians (NRIs), overseas citizens of India (OCIs), and foreign nationals without requiring Indian tax filings, provided their only India-sourced income is from GIFT City. The fund also eases regulatory barriers for Indian residents looking to invest in foreign startups by bypassing some of the complexities associated with ODI and SEBI approvals. According to IPV, the fund intends to use GIFT City's platform to tap into cross-border opportunities and engage more directly with international startup ecosystems. The framework allows for a unified regulatory regime that aims to be more flexible and innovation-oriented compared to domestic structures. The launch of IPV International follows IPV's six-year track record of startup investments, including over 220 portfolio companies and 50 exits. IPV also operates Physis Capital, a USD 50 million Category II VC fund focused on growth-stage startups. As cross-border capital flows become more central to the global startup ecosystem, IPV International's launch reflects a growing trend among Indian investment platforms to leverage GIFT City's infrastructure for international outreach, investor diversification, and regulatory efficiency.
